HSDT

Helius Medical Technologies Inc Class A

HSDT, USA

Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.

https://www.solanacompany.co

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HSDT
stock
HSDT

U.S. stocks closed with the crypto sector rising against the trend, Solana (HSDT) up 6.45% Bitget

Read more →
HSDT
stock
HSDT

Solana Stock Drop Looks Sharp, But How Deep Can It Go? Trefis

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$4

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.05

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

231.49 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-74.12 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-580.20 %

Low ≤ 5%

High ≥ 15%

Investors

* Institutions hold a combined 0.01% of the total shares of Helius Medical Technologies Inc Class A

1.

Fidelity Extended Market Index

(0.0035%)

since

2025/07/31

2.

Vanguard Institutional Extnd Mkt Idx Tr

(0.001%)

since

2025/07/31

3.

Fidelity Series Total Market Index

(0.0007%)

since

2025/07/31

4.

SBI Securities Co Ltd

(0.0001%)

since

2025/06/30

5.

NT Ext Equity Mkt Idx Fd - L

(0.0001%)

since

2025/06/30

6.

CoreCap Advisors, LLC

(0%)

since

2025/06/30

9.

Virtu Financial LLC

(0%)

since

2025/03/31

10.

Advisor Group Holdings, Inc.

(0%)

since

2025/03/31

11.

Fedenia Advisers LLC

(0%)

since

2025/03/31

12.

St Germain D J Co Inc

(0%)

since

2025/06/30

13.

TWO SIGMA SECURITIES, LLC

(0%)

since

2025/03/31

14.

Citigroup Inc

(0%)

since

2025/03/31

15.

HRT FINANCIAL LLC

(0%)

since

2025/03/31

16.

UBS Group AG

(0%)

since

2025/03/31

17.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0%)

since

2024/12/31

18.

NT Ext Equity Mkt Idx Fd - NL

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-32.89

EPS Estimate

-50.5

EPS Difference

17.61

Surprise Percent

34.8713%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(4.5)
Growth
Moderate Growth(4.5)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(1.5)
Quality
Low Quality Business(3)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.